tm
Seeing Is Believing
tm
Seeing Is Believing
VERV is currently covered by 4 analysts with an average price target of $29.11. This is a potential upside of $21.5 (282.52%) from yesterday's end of day stock price of $7.61.
Verve Therapeutics's activity chart (see below) currently has 16 price targets and 27 ratings on display. The stock rating distribution of VERV is 30.77% HOLD and 69.23% BUY.
Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 19.43 days.
Highest price target for VERV is $32, Lowest price target is $17, average price target is $29.11.
Most recent stock forecast was given by LUCA ISSI from RBC on 06-Nov-2024. First documented stock forecast 12-Jul-2021.
Currently out of the existing stock ratings of VERV, 4 are a HOLD (30.77%), 9 are a BUY (69.23%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$17
$9.39 (123.39%)
$20
2 months 26 days ago
(06-Nov-2024)
0/6 (0%)
$10.51 (161.94%)
Buy
$32
$24.39 (320.50%)
$29
2 months 26 days ago
(06-Nov-2024)
0/5 (0%)
$25.51 (393.07%)
Hold
$22
$14.39 (189.09%)
$22
1 years 4 months 19 days ago
(13-Sep-2023)
1/3 (33.33%)
$9 (69.23%)
8
Hold
$31
$23.39 (307.36%)
$48
1 years 5 months 21 days ago
(11-Aug-2023)
0/2 (0%)
$13.02 (72.41%)
Buy
$56
$48.39 (635.87%)
$34
2 years 5 months 7 days ago
(25-Aug-2022)
1/4 (25%)
$14.69 (35.56%)
128
What is VERV (Verve Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VERV (Verve Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VERV (Verve Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VERV (Verve Therapeutics)?
Which analyst is the currently most bullish on VERV (Verve Therapeutics)?
Which analyst is the currently most reserved on VERV (Verve Therapeutics)?
